ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1096

Augmentation of Wnt Signaling By IL-1β in Fibroblast-like Synoviocytes

Satoshi Yamasaki1, Yusuke Yoshida2 and Eiji Sugiyama2, 1Hiroshima University Hospital, Hiroshima, Japan, 2Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: cytokines, IL-1, osteoblasts and synovial cells, synovial fluid, WNT Signaling

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Biology and Pathology of Bone and Joint - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Wnt family proteins canonically stabilize β-catenin to activate T-cell factor (TCF) for the transcription of several genes, including Runx2, which is important for osteoblastogenesis. Wnt transcripts are highly expressed in RA synovia (Am J Pathol. 2005; 167: 97–105), suggesting the role of Wnt signaling in bone metabolism during articular disease development. Interestingly, fibroblast-like synoviocytes (FLS) also produce remarkable amount of Dickkopf1 (DKK1), a soluble protein that blocks Wnt pathway. Therefore, FLS have both positive and negative effects on Wnt signal activation. It is plausible that a change in WNT and DKK1 expression can affect the strength of Wnt signaling and regulate bone metabolism and joint destruction in articular diseases. In this study, we aimed to determine the cytokines that regulate Wnt signaling in FLS.

Methods: The mRNA expression levels of Wnt1, 2, 3, 3a, 4, 5a, 5b, 7b, 8b, 10A, 10B, 11, DKK1, and Runx2 in FLS were quantified by SYBR green real-time PCR after treatment with cytokines (TNFα, IL-1β, IL-6, IL-17, and IFNγ). Activity of Wnt pathway was assessed by luciferase assay using TCF reporter plasmid, which was transfected to U2OS, an osteosarcoma cell line that lacks DKK1 expression. The concentration of DKK1 in the culture media was measured by ELISA. Anti-DKK1 antibodies were used to neutralize DKK1 in FLS culture medium.

Results: FLS expresses mRNA of Wnt2, 3, 4, 5A, 5B, 7B, 8B 10A, 10B, 11, and DKK1. DKK1 secreted by FLS was functional, as it blocked the activation of TCF luciferase activity induced by recombinant Wnt3a, and was effectively blocked by anti-DKK1 antibody. TNFα and IL-6 induced Wnt2, 4, and Wnt4 mRNA levels in FLS, respectively, whereas, IL-1β increased Wnt2, 5A, 7B, 10A, 10B, and 11 mRNA levels. Importantly, IL-1β dampened DKK1 mRNA expression in FLS, but TNFα and IL-6 did not alter its expression. Consistent with these results, luciferase activity was induced by the supernatant of FLS treated with IL-1β, but not with other cytokines. In addition, Runx2 mRNA expression in FLS was induced by only IL-1β.

Conclusion: Our data indicates that IL-1β has the highest potential to enhance Wnt signaling, among the tested cytokines. It is already known that IL-1β induces phosphorylation of glycogen synthase kinase-3β for the activation of transcriptional factor TCF. Our findings demonstrate that IL-1β also activates the canonical Wnt signaling pathway by changing the expression pattern of Wnt family proteins and DKK1 in FLS. It is suggested that IL-1β, but not the other cytokines, changes the gene expression pattern of Wnt family and DKK1 in FLS to up-regulate Wnt signaling in the joint during aberrant bone formation.


Disclosure: S. Yamasaki, Eli Lilly and Company, 2; Y. Yoshida, None; E. Sugiyama, Eli Lilly and Company, 2,Bristol-Myers Squibb, 2,Actelion Pharmaceuticals US, 2.

To cite this abstract in AMA style:

Yamasaki S, Yoshida Y, Sugiyama E. Augmentation of Wnt Signaling By IL-1β in Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/augmentation-of-wnt-signaling-by-il-1%ce%b2-in-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/augmentation-of-wnt-signaling-by-il-1%ce%b2-in-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology